Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Exploring the Role of Capicua (CIC) Mutations in Oligodendrogliomas

FY 2014-15

Summary
Canadian Cancer Statistics estimates that approximately 2,300 Canadians developed gliomas, a type of brain tumour, in 2014 alone. Glioblastomas, the most common and severe type of glioma, exhibit a median survival of only 15 months. Despite their relatively common occurrence, current therapies against gliomas are often only marginally effective, and new, more effective treatments are desperately needed. Oligodendrogliomas (ODGs) are lower-grade gliomas that are of particular interest because they generally present a better prognosis than their high-grade counterparts. Cancers in general are genetic diseases that arise when mutations occur in key genes. A gene can be defined as a discrete unit of DNA that contains instructions used by the cell to construct specific proteins. Proteins, in turn, are essentially the functional units of the cell, and most have very specific roles. Many types and subtypes of cancers are characterized by specific recurrent mutations that contribute to the behaviour of that particular tumour. This holds true for ODGs, which are associated with specific genetic abnormalities that include frequent mutations in a gene named Capicua (CIC). Though CIC is able to alter the expression of certain genes in order to modulate the amount of protein they produce, only some of its target genes are known. We therefore first intend to establish CIC’s interaction network throughout the genome. We also intend to determine how specific recurrent affect the function of CIC, providing us with insight into how they contribute to ODG pathology. These studies will provide us with a more thorough and comprehensive understanding of CIC’s function and its role in ODGs, and may reveal novel therapeutic targets for improved glioma therapy.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331383
Name
LeBlanc Veronique G
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the Role of Capicua (CIC) Mutations in Oligodendrogliomas
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer Biology; Cancer Genomics; Glioma; Tissue Culture; Transcription Factor
Abstract
Canadian Cancer Statistics estimates that approximately 2,300 Canadians developed gliomas, a type of brain tumour, in 2014 alone. Glioblastomas, the most common and severe type of glioma, exhibit a median survival of only 15 months. Despite their relatively common occurrence, current therapies against gliomas are often only marginally effective, and new, more effective treatments are desperately needed. Oligodendrogliomas (ODGs) are lower-grade gliomas that are of particular interest because they generally present a better prognosis than their high-grade counterparts. Cancers in general are genetic diseases that arise when mutations occur in key genes. A gene can be defined as a discrete unit of DNA that contains instructions used by the cell to construct specific proteins. Proteins, in turn, are essentially the functional units of the cell, and most have very specific roles. Many types and subtypes of cancers are characterized by specific recurrent mutations that contribute to the behaviour of that particular tumour. This holds true for ODGs, which are associated with specific genetic abnormalities that include frequent mutations in a gene named Capicua (CIC). Though CIC is able to alter the expression of certain genes in order to modulate the amount of protein they produce, only some of its target genes are known. We therefore first intend to establish CIC’s interaction network throughout the genome. We also intend to determine how specific recurrent affect the function of CIC, providing us with insight into how they contribute to ODG pathology. These studies will provide us with a more thorough and comprehensive understanding of CIC’s function and its role in ODGs, and may reveal novel therapeutic targets for improved glioma therapy.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
LeBlanc, Veronique G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~